I just witnessed the absolute highlight of today’s J.P. Morgan Healthcare conference.
To say it’s standing room only at the 23andMe presentation is terribly inaccurate – you can’t even make it in the doorway. Looks like this from my standpoint:
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Can’t get in the doorway.
Another person that seemed to have a hard time getting into the 23andMe presentation? CEO Anne Wojcicki.
She didn’t seem to mind, though. As President Andy Page led the barely audible presentation about the hot consumer genomics company, Wojcicki hung back, chatting. Loudly.
So homegirl in the glasses above shushed her. Loudly.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
This is Wojcicki apologizing for being a touch too boisterous during the 23andMe presentation:
Amazeballs.
(Also, there was apparently nothing particularly newsworthy discussed during the 23andMe presentation. So Wojcicki’s OK.)